American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6409)
  2. Solid Tumor Oncology Division (5547)
  3. Survivorship Research (2000)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1642)
  6. Epidemiology and Biostatistics (1497)
  7. GSK Faculty (1389)
  8. Population Sciences Research Program (1382)
  9. Gastrointestinal Oncology Service (1356)
  10. Hematologic Malignancies, Division of (1286)
Search Within
Formats
  1. Meeting Abstract (6344)
  2. Journal Article (2591)
  3. Editorial (79)
  4. Review (70)
  5. Guidelines (55)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6409)
  2. Solid Tumor Oncology Division (5547)
  3. Survivorship Research (2000)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1642)
  6. Epidemiology and Biostatistics (1497)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (308)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (303)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8712)
  2. JCO Precision Oncology (174)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (54)
  6. JCO Oncology Practice (12)

More Publications

Results (9195)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of nab- sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (AMPECT): Long-term efficacy and safety update
    Journal Article

    Wagner, A. J.; Ravi, V.; Riedel, R. F.; Ganjoo, K.; Van Tine, B. A.; Chugh, R.; Cranmer, L.; Gordon, E. M.; Hornick, J. L.; Du, H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Long-term follow-up of the anthracyclines in early breast cancer trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology])
    Journal Article

    Geyer, C. E.; Blum, J. L.; Yothers, G.; Asmar, L.; Flynn, P. J.; Robert, N. J.; Hopkins, J. O.; O'Shaughnessy, J. A.; Rastogi, P.; Puhalla, S. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Genomic classification and individualized prognosis in multiple myeloma
    Journal Article

    Maura, F.; Rajanna, A. R.; Ziccheddu, B.; Poos, A. M.; Derkach, A.; Maclachlan, K.; Durante, M.; Diamond, B.; Papadimitriou, M.; Davies, F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Prophylactic radiation therapy for high-risk asymptomatic bone metastases: A new standard of care or need for more data?
    Correspondence

    Chan, A. W.; Simone, C. B.; Van Der Linden, Y.; Hoskin, P.; Detsky, J.; Choi, J. I.; Lee, S. F.; Wong, H. C. Y.; Martin, E. J.; Raman, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Reply to A.W. Chan et al
    Correspondence

    Gillespie, E. F.; Vaynrub, M.; Yang, J. T.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab versus sunitinib in first-line treatment of advanced renal cell carcinoma: Final prespecified overall survival analysis of CLEAR, a phase III study
    Journal Article

    Motzer, R. J.; Porta, C.; Eto, M.; Powles, T.; Grünwald, V.; Hutson, T. E.; Alekseev, B.; Rha, S. Y.; Merchan, J.; Goh, J. C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Methodology for using real-world data from electronic health records to assess chemotherapy administration in women with breast cancer
    Journal Article

    Bhimani, J.; O'Connell, K.; Ergas, I. J.; Foley, M.; Gallagher, G. B.; Griggs, J. J.; Heon, N.; Kolevska, T.; Kotsurovskyy, Y.; Kroenke, C. H.; more...
    JCO Clinical Cancer Informatics (2024)

    Fulltext@MSK | Save
  • Lisocabtagene maraleucel in relapsed/refractory mantle cell lymphoma: Primary analysis of the mantle cell lymphoma cohort from TRANSCEND NHL 001, a phase I multicenter seamless design study
    Journal Article

    Wang, M.; Siddiqi, T.; Gordon, L. I.; Kamdar, M.; Lunning, M.; Hirayama, A. V.; Abramson, J. S.; Arnason, J.; Ghosh, N.; Mehta, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Radiographic progression-free survival and clinical progression-free survival as potential surrogates for overall survival in men with metastatic hormone-sensitive prostate cancer
    Journal Article

    Halabi, S.; Roy, A.; Rydzewska, L.; Guo, S.; Godolphin, P.; Hussain, M.; Tangen, C.; Thompson, I.; Xie, W.; Carducci, M. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Secondary analysis of the rate of second primary lung cancer from cancer and leukemia group B 140503 (Alliance) trial of lobar versus sublobar resection for T1aN0 non–small-cell lung cancer
    Journal Article

    Stinchcombe, T. E.; Wang, X.; Damman, B.; Mentlick, J.; Landreneau, R.; Wigle, D.; Jones, D. R.; Conti, M.; Ashrafi, A. S.; Liberman, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save